Research conducted in the field identified 14 injury criteria associated with dicamba (Clarity® diglycolamine salt) applied at 0.6 to 280 g ae ha^-1 (1/1,000 to 1/2 of 560 g ha^-1 use rate) to indeterminate soybean at V3/V4 or R1/R2. For each criterion, injury was rated using a scale of 0=no injury, 1=slight, 2= slight to moderate, 3=moderate, 4=moderate to severe, and 5=severe. Greatest crop injury 15 d after treatment (DAT) was observed for dicamba rates of 0.6 to 4.4 g ha^-1 for upper canopy pale leaf margins (3.8 to 4.2) at V3/V4 and for terminal leaf cupping (4.1 to 5.0) at R1/R2, and for rates of 0.6 to 8.8 g ha^-1 for upper canopy leaf cupping (3.8 to 4.8) and upper canopy leaf surface crinkling (3.4 to 4.4) at V3/V4. Injury 15 DAT was equivalent to the nontreated control for dicamba rates as high as 4.4 g ha^-1 for lower stem base swelling at V3/V4 and for upper canopy leaf rollover/inversion and terminal leaf necrosis at R1/R2; for rates as high as 8.8 g ha^-1 for leaf petiole base swelling and stem epinasty at R1/ R2, and lower stem base lesions/cracking (V3/V4 and R1/R2 average); and for rates as high as 17.5 g ha^-1 for lower leaf soil contact at V3/V4 and leaf petiole droop at R1/R2. The response to increasing dicamba rate observed for the injury criteria was in contrast to the steady increase in visual injury and plant height reduction rated as 0 to 100%. The moderate to severe upper canopy leaf cupping, pale leaf margins, and leaf surface crinkling, and terminal leaf cupping 15 DAT with dicamba at 0.6 to 4.4 g ha^-1 corresponded to soybean yield loss of 1% to 9% for application at V3/V4 and 2% to 17% at R1/R2.

Nomenclature: Dicamba; soybean, Glycine max (L.) Merr